BEATMeth: Beginning Early and Assertive Treatment for Methamphetamine Use Disorder
Study Details
Study Description
Brief Summary
The overall goal of the study is to evaluate the effectiveness of a secondary prevention strategy implemented at a systems-level to prevent stimulant related overdoses.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
To date, a public health systems approach to enhance linkage and engagement in care for stimulant use disorders is lacking. This shortcoming arises in part from the lack of effective treatments for stimulant use disorders (StUD), the specific pathology of methamphetamine use, and gaps in epidemiologic knowledge related to methamphetamine use disorder. Unlike opioid use disorders, for which medications relieve dysphoric symptoms of acute withdrawal and prevent relapse, patients with StUD present to care with methamphetamine-induced psychosis and may be combative, agitated, and poorly insightful to their need for treatment. In response to community demands, our team at Denver Health recently established a pilot program, Beginning Early and Assertive Treatment for Methamphetamine Use Disorder (BEAT Meth), to protocolize the assessment and treatment of patients with methamphetamine-induced psychosis.The current research project aims to develop and conduct process and outcomes evaluations of a linkage intervention aimed at increasing continuation and engagement in treatment for stimulant use disorder.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Intervention Dedicated care navigator to address social support needs |
Behavioral: care navigation
Dedicated care navigation throughout study enrollment and follow-up period. Care navigation consists of addressing social support needs (e.g. transportation, communication, housing).
|
| No Intervention: Usual care Standard of care. |
Outcome Measures
Primary Outcome Measures
- Number of participants who entered treatment for methamphetamine use disorder [within 30 of study enrollment]
Treatment entry as defined as attendance at an outpatient addiction treatment appointment within 30 days of BEAT Meth discharge
Secondary Outcome Measures
- Number of participants retained in treatment at 30 days [30 days]
Retention in treatment at 30 days
- Number of participants who overdosed [through study completion, an average of 1 year]
non-fatal overdose as self-reported and fatal overdose from medical examiner
- Number of participants retained in treatment at 90 days [90 days]
Retention in treatment at 90 days
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 years of age and older
-
identified in the Denver Health healthcare system who have had a methamphetamine-related encounter at Denver Health
Exclusion Criteria:
-
unable to complete the interview in English
-
intoxicated or impaired and unable to consent to participate in the project and/or respond to the interview
-
currently under residential involuntary psychiatric or substance treatment order (i.e., mental health hold, emergency commitment, or short-term certification)
-
received any type of substance use treatment at DHHA in the last 90 days
-
planning to enter substance treatment
-
unable to complete the research visits in the next 90 days
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Denver Health | Denver | Colorado | United States | 80204 |
Sponsors and Collaborators
- Denver Health and Hospital Authority
- Centers for Disease Control and Prevention
Investigators
- Principal Investigator: Alia A Al-Tayyib, PhD, Denver Health
Study Documents (Full-Text)
More Information
Publications
None provided.- 22-0968
- R01CE003363